Faecalibacterium prausnitzii upregulates regulatory T cells and anti-inflammatory cytokines in treating TNBS-induced colitis (Q46365627)

21 December 2017

title

Faecalibacterium prausnitzii upregulates regulatory T cells and anti-inflammatory cytokines in treating TNBS-induced colitis (English)

1 reference

21 December 2017

Faecalibacterium prausnitzii

main subject

inflammation

0 references

object named as

Faecalibacterium prausnitzii

1 reference

0 references

Xinyun Qiu

1

1 reference

21 December 2017

Mingming Zhang

2

1 reference

21 December 2017

Xiaotong Yang

3

1 reference

21 December 2017

Na Hong

4

1 reference

21 December 2017

Chenggong Yu

5

1 reference

21 December 2017

publication date

2 May 2013

1 reference

21 December 2017

Journal of Crohn's and Colitis

published in

1 reference

21 December 2017

volume

7

1 reference

21 December 2017

page(s)

e558-68

1 reference

21 December 2017

issue

11

1 reference

21 December 2017

Probiotic microbes: do they need to be alive to be beneficial?

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2013.04.002

Interactions between the microbiota and the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2013.04.002

Dysbiosis in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2013.04.002

Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2013.04.002

Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2013.04.002

Low counts of Faecalibacterium prausnitzii in colitis microbiota.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2013.04.002

VIP in inflammatory bowel disease: state of the art.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2013.04.002

Regulatory T-cell therapy for inflammatory bowel disease: more questions than answers

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2013.04.002

Imbalance of T-cell transcription factors contributes to the Th1 type immunity predominant in pre-eclampsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2013.04.002

New insights into the dichotomous role of innate cytokines in gut homeostasis and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2013.04.002

Proinflammatory cytokines in the pathogenesis of inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2013.04.002

Mechanisms of action of probiotics: recent advances

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2013.04.002

Correlation between in vitro and in vivo immunomodulatory properties of lactic acid bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2013.04.002

Differential inflammatory mediator response in vitro from murine macrophages to lactobacilli and pathogenic intestinal bacteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2013.04.002

CD4 T-cell differentiation and inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2013.04.002

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2013.04.002

Foxp3+ regulatory T cells, Th17 effector cells, and cytokine environment in inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2013.04.002

New pathogenic paradigms in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2013.04.002

Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2013.04.002

FoxP3, GATA-3 and T-bet expression in elderly asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2013.04.002

Probiotics ameliorate recurrent Th1-mediated murine colitis by inducing IL-10 and IL-10-dependent TGF-beta-bearing regulatory cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2013.04.002

Anti-inflammatory effects of probiotic yogurt in inflammatory bowel disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2013.04.002

Probiotic administration in patients with ileal pouch-anal anastomosis for ulcerative colitis is associated with expansion of mucosal regulatory cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2013.04.002

Reciprocal modulation between TH17 and other helper T cell lineages

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2013.04.002

10.1016/J.CROHNS.2013.04.002

21 January 2018

Identifiers

DOI

1 reference

21 December 2017

PubMed ID

23643066

1 reference

21 December 2017